D. Y. Wang

774 total citations
20 papers, 452 citations indexed

About

D. Y. Wang is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, D. Y. Wang has authored 20 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in D. Y. Wang's work include Cancer Risks and Factors (10 papers), Metabolism, Diabetes, and Cancer (6 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). D. Y. Wang is often cited by papers focused on Cancer Risks and Factors (10 papers), Metabolism, Diabetes, and Cancer (6 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). D. Y. Wang collaborates with scholars based in United Kingdom, Netherlands and United States. D. Y. Wang's co-authors include H. G. Kwa, J.L. Hayward, Ian S. Fentiman, F. J. Cleton, R.D. Bulbrook, R.D. Bulbrook, Rosemary R. Millis, Susan Hoare, G.M.G. Clark and John W. Moore and has published in prestigious journals such as Cancer, Annals of the New York Academy of Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

D. Y. Wang

20 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Y. Wang United Kingdom	12	212	143	109	109	101	20	452
M. M. Brentani Brazil	13	100 0.5×	101 0.7×	50 0.5×	96 0.9×	63 0.6×	29	390
Babak Dehghani United States	6	131 0.6×	217 1.5×	52 0.5×	92 0.8×	18 0.2×	8	490
Yoshiyuki Kinoshita Japan	10	88 0.4×	170 1.2×	27 0.2×	38 0.3×	32 0.3×	14	449
Peter J. Gkonos United States	15	129 0.6×	65 0.5×	49 0.4×	160 1.5×	25 0.2×	20	568
Holly Dushkin United States	12	155 0.7×	126 0.9×	46 0.4×	11 0.1×	67 0.7×	18	455
Francisco Tejada Cifuentes Spain	15	104 0.5×	63 0.4×	48 0.4×	16 0.1×	32 0.3×	38	537
Lori Iwasaki United States	12	74 0.3×	249 1.7×	104 1.0×	125 1.1×	79 0.8×	14	637
Julie Neidich United States	17	73 0.3×	231 1.6×	57 0.5×	40 0.4×	50 0.5×	42	698
Soichiro Shizawa Japan	9	52 0.2×	101 0.7×	16 0.1×	166 1.5×	95 0.9×	10	453
Darcy L. Thull United States	13	180 0.8×	102 0.7×	197 1.8×	47 0.4×	152 1.5×	18	468

Countries citing papers authored by D. Y. Wang

Since Specialization

Citations

This map shows the geographic impact of D. Y. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Y. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Y. Wang more than expected).

Fields of papers citing papers by D. Y. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Y. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Y. Wang. The network helps show where D. Y. Wang may publish in the future.

Co-authorship network of co-authors of D. Y. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of D. Y. Wang. A scholar is included among the top collaborators of D. Y. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Y. Wang. D. Y. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Yi‐Wen, et al.. (2001). Possible cofactor in cervical carcinogenesis: proliferation index of the transformation zone in cervicitis.. PubMed. 24(10). 615–20. 13 indexed citations

Wang, D. Y., H. Hamed, & IS Fentiman. (1990). Epidermal Growth Factor and Insulinlike Growth Factor‐I in Human Breast Cyst Fluid. Annals of the New York Academy of Sciences. 586(1). 158–160. 7 indexed citations

Wang, D. Y., et al.. (1988). Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity.. Journal of Pharmacology and Experimental Therapeutics. 245(1). 124–128. 29 indexed citations

Wang, D. Y., R.D. Rubens, G.M.G. Clark, John W. Moore, & R.D. Bulbrook. (1988). Effects of prednisolone on sex hormone binding globulin during primary endocrine treatment of advanced breast cancer. Breast Cancer Research and Treatment. 11(1). 67–70. 7 indexed citations

Bulbrook, R.D., John W. Moore, B.S. Thomas, et al.. (1988). Sex Hormone‐Binding Globulin and the Natural History of Breast Cancer. Annals of the New York Academy of Sciences. 538(1). 248–256. 8 indexed citations

Moore, John W., G.M.G. Clark, Susan Hoare, et al.. (1986). Binding of oestradiol to blood proteins and aetiology of breast cancer. International Journal of Cancer. 38(5). 625–630. 51 indexed citations

Fentiman, IS, Maira Caleffi, D. Y. Wang, et al.. (1986). Diurnal variations in prolactin and growth hormone levels in normal premenopausal vegetarian and omnivorous women. Nutrition and Cancer. 8(4). 239–245. 6 indexed citations

Wang, D. Y., H. G. Kwa, & R.D. Bulbrook. (1986). Is the Decreased Risk of Breast Cancer due to Early Age at First Baby and Multiparity Mediated by Prolactin?. Annals of the New York Academy of Sciences. 464(1). 460–462. 1 indexed citations

Wang, D. Y. & Ian S. Fentiman. (1985). Epidemiology and endocrinology of benign breast disease. Breast Cancer Research and Treatment. 6(1). 5–36. 79 indexed citations

10.

Wang, D. Y., DS Allen, R.D. Bulbrook, et al.. (1985). Influence of reproductne history on age at diagnosis of breast cancer and prognosis. International Journal of Cancer. 36(4). 427–432. 14 indexed citations

11.

Hoare, Susan, et al.. (1984). Urinary hydroxyproline and prognosis in human breast cancer. British journal of surgery. 71(2). 105–108. 7 indexed citations

12.

Bulbrook, R.D., D. Y. Wang, J.L. Hayward, H. G. Kwa, & F. J. Cleton. (1981). Plasma prolactin levels and age in a female population: Relation to breast cancer. International Journal of Cancer. 28(1). 43–45. 21 indexed citations

13.

Kwa, H. G., F. J. Cleton, R.D. Bulbrook, D. Y. Wang, & J.L. Hayward. (1981). Plasma prolactin levels and breast cancer: Relation to parity, weight and height, and age at first birth. International Journal of Cancer. 28(1). 31–34. 58 indexed citations

14.

Kwa, H. G., F. J. Cleton, D. Y. Wang, et al.. (1981). A prospective study of plasma prolactin levels and subsequent risk of breast cancer. International Journal of Cancer. 28(6). 673–676. 36 indexed citations

15.

Wang, D. Y., P. R. Goodwin, R.D. Bulbrook, et al.. (1979). Plasma iga, igg and igm and their relationship to breast cancer in british, japanese and hawaiian-japanese women. Cancer. 44(2). 492–494. 2 indexed citations

16.

Kwa, H. G., et al.. (1978). Abnormalites in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease. International Journal of Cancer. 22(6). 687–690. 14 indexed citations

17.

Kwa, H. G., R.D. Bulbrook, F. J. Cleton, et al.. (1978). An abnormal early evening peak of plasma prolactin in nulliparous and obese post‐menopausal women. International Journal of Cancer. 22(6). 691–693. 19 indexed citations

18.

Kwa, H. G. & D. Y. Wang. (1977). An abnormal luteal‐phase evening peak of plasma prolactin in women with a family history of breast cancer. International Journal of Cancer. 20(1). 12–14. 40 indexed citations

19.

Kwa, H. G., F. J. Cleton, M. De Jong‐Bakker, et al.. (1976). Plasma prolactin and its relationship to risk factors in human breast cancer. International Journal of Cancer. 17(4). 441–447. 32 indexed citations

20.

Wang, D. Y., et al.. (1972). Hormones in the aetiology and clinical course of breast cancer.. PubMed. 39. 177–83. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact